WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection Recommendations for a public health approach - Second edition. 2016.
El-Sadr WM, Goosby E. Building on the HIV platform: tackling the challenge of noncommunicable diseases among persons living with HIV. AIDS (London, England). 2018;32:S1–3.
Article
Google Scholar
WHO. Global Health Observatory Data. NCD mortality and morbidity. 2018 [Available from: http://www.who.int/gho/ncd/mortality_morbidity/en/.
WHO. Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020. 2013.
Levitt NS, Steyn K, Dave J, Bradshaw D. Chronic noncommunicable diseases and HIV-AIDS on a collision course: relevance for health care delivery, particularly in low-resource settings - insights from South Africa. Am J Clin Nutr. 2011;94(6):1690S–6S.
Article
Google Scholar
Ministry of Health. Kenya National Strategy for the Prevention and Control of Non-Communicable Diseases 2015-2020. 2015.
UNAIDS. Global AIDS Update 2016.
Farahani M, Vable A, Lebelonyane R, Seipone K, Anderson M, Avalos A, et al. Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis. Lancet Glob Health. 2014;2(1):e44–50.
Article
Google Scholar
Miszkurka M, Haddad S, Langlois EV, Freeman EE, Kouanda S, Zunzunegui MV. Heavy burden of non-communicable diseases at early age and gender disparities in an adult population of Burkina Faso: world health survey. BMC Public Health. 2012;12:24.
Article
Google Scholar
Kenya National Bureau of Statistics, Ministry of Health Kenya, World Health Organization. Kenya STEPwise Survey for Non Communicable Diseases Risk Factors 2015 Report. 2015.
National AIDS Control council (NACC), National AIDS/STD control Programme (NASCOP). Kenya HIV Estimates 2015. 2016.
Bloomfield GS, Khazanie P, Morris A, Rabadan-Diehl C, Benjamin LA, Murdoch D, et al. HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future research. J Acquir Immune Defic Syndr (1999). 2014;67 Suppl 1:S40–53.
Article
Google Scholar
Narayan KM, Miotti PG, Anand NP, Kline LM, Harmston C, Gulakowski R 3rd, et al. HIV and noncommunicable disease comorbidities in the era of antiretroviral therapy: a vital agenda for research in low- and middle-income country settings. J Acquir Immune Defic Syndr (1999). 2014;67 Suppl 1:S2–7.
Article
Google Scholar
Magodoro IM, Esterhuizen TM, Chivese T. A cross-sectional, facility based study of comorbid non-communicable diseases among adults living with HIV infection in Zimbabwe. BMC Res Notes. 2016;9:379.
Article
Google Scholar
Kavishe B, Biraro S, Baisley K, Vanobberghen F, Kapiga S, Munderi P, et al. High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in northwestern Tanzania and southern Uganda. BMC Med. 2015;13:126.
Article
Google Scholar
Edwards JK, Bygrave H, Van den Bergh R, Kizito W, Cheti E, Kosgei RJ, et al. HIV with non-communicable diseases in primary care in Kibera, Nairobi, Kenya: characteristics and outcomes 2010-2013. Trans R Soc Trop Med Hyg. 2015;109(7):440–6.
Article
Google Scholar
Peck RN, Shedafa R, Kalluvya S, Downs JA, Todd J, Suthanthiran M, et al. Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: a cross-sectional study. BMC Med. 2014;12:125.
Article
Google Scholar
Kagaruki GB, Mayige MT, Ngadaya ES, Kimaro GD, Kalinga AK, Kilale AM, et al. Magnitude and risk factors of non-communicable diseases among people living with HIV in Tanzania: a cross sectional study from Mbeya and Dar Es Salaam regions. BMC Public Health. 2014;14:904.
Article
Google Scholar
Mutasa-Apollo T, Shiraishi RW, Takarinda KC, Dzangare J, Mugurungi O, Murungu J, et al. Patient retention, clinical outcomes and attrition-associated factors of HIV-infected patients enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007-2010. PLoS One. 2014;9(1):e86305.
Article
Google Scholar
WHO. Consolidated Guidelines on the use of Antiretroviral Drugs for Treating and Preventing Hiv Infection Recommendations For A Public Health Approach. 2013.
Ministry of Health GoK. Guidelines to Antiretroviral Drug Therapy in Kenya. 2001.
Ministry of Health GoK. Guidelines for Antiretroviral Drug Therapy in Kenya. 3rd ed2005.
Ministry of Health GoK. Guidelines for Antiretroviral therapy in Kenya. 4th ed2011.
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint National Committee (JNC 8). Jama. 2014;311(5):507–20.
Article
CAS
Google Scholar
May MT, Gompels M, Delpech V, Porter K, Orkin C, Kegg S, et al. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS (London, England). 2014;28(8):1193–202.
Article
Google Scholar
Trickey A, May MT, Vehreschild J-J, Obel N, Gill MJ, Crane HM, et al. Survival of HIV-positive patients starting antiretroviral therapy between 1996 And 2013: a collaborative analysis of cohort studies. Lancet HIV. 4(8):e349–e56.
Vorkoper S, Kupfer LE, Anand N, Patel P, Beecroft B, Tierney WM, et al. Building on the HIV chronic care platform to address noncommunicable diseases in sub-Saharan Africa: a research agenda. AIDS (London, England). 2018;32:S107–S13.
Article
Google Scholar
van Heerden A, Barnabas RV, Norris SA, Micklesfield LK, van Rooyen H, Celum C. High prevalence of HIV and non-communicable disease (NCD) risk factors in rural KwaZulu-Natal, South Africa. J Int AIDS Soc. 2017;20(2). https://onlinelibrary.wiley.com/doi/full/10.1002/jia2.25012.
Patel P, Rose CE, Collins PY, Nuche-Berenguer B, Sahasrabuddhe VV, Peprah E, et al. Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis. AIDS (London, England). 2018;32:S5–S20.
Article
Google Scholar
Zolopa A, Andersen J, Powderly W, Sanchez A, Sanne I, Suckow C, et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One. 2009;4(5):e5575.
Article
Google Scholar
Ministry of Health National AIDS & STI Control Programme. Guidelines on Use of Antiretroviral Drugs for Treating and Preventing HIV Infection in Kenya 2016.
Tripathi A, Liese AD, Jerrell JM, Zhang J, Rizvi AA, Albrecht H, et al. Incidence of diabetes mellitus in a population-based cohort of HIV-infected and non-HIV-infected persons: the impact of clinical and therapeutic factors over time. Diabet Med. 2014;31(10):1185–93.
Article
CAS
Google Scholar
Rasmussen LD, Mathiesen ER, Kronborg G, Pedersen C, Gerstoft J, Obel N. Risk of diabetes mellitus in persons with and without HIV: a Danish nationwide population-based cohort study. PLoS One. 2012;7(9):e44575.
Article
CAS
Google Scholar
Oni T, Youngblood E, Boulle A, McGrath N, Wilkinson RJ, Levitt NS. Patterns of HIV, TB, and non-communicable disease multi-morbidity in peri-urban South Africa- a cross sectional study. BMC Infect Dis. 2015;15:20.
Article
Google Scholar
Dave JA, Lambert EV, Badri M, West S, Maartens G, Levitt NS. Effect of nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy on dysglycemia and insulin sensitivity in South African HIV-infected patients. J Acquir Immune Defic Syndr (1999). 2011;57(4):284–9.
Article
CAS
Google Scholar
Tien PC, Schneider MF, Cole SR, Levine AM, Cohen M, DeHovitz J, et al. Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study. AIDS (London, England). 2007;21(13):1739–45.
Article
CAS
Google Scholar
Nduka CU, Stranges S, Sarki AM, Kimani PK, Uthman OA. Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: a systematic review with meta-analysis. J Hum Hypertens. 2016;30(6):355–62.
Article
CAS
Google Scholar
Kwarisiima D, Balzer L, Heller D, Kotwani P, Chamie G, Clark T, et al. Population-based assessment of hypertension epidemiology and risk factors among HIV-positive and general populations in rural Uganda. PLoS One. 2016;11(5):e0156309.
Article
Google Scholar
Rabkin M, Palma A, McNairy ML, Gachuhi AB, Simelane S, Nuwagaba-Biribonwoha H, et al. Integrating cardiovascular disease risk factor screening into HIV services in Swaziland: lessons from an implementation science study. AIDS (London, England). 2018;32:S43–S6.
Article
Google Scholar
Haregu TN, Oldenburg B, Sestwe G, Elliott J, Nanayakkara V. Epidemiology of Comorbidity of HIV/AIDS and Non-communicable Diseases in Developing Countries: A systematic review. J Glob Health Care Syst. 2012;2(1).
Sander LD, Newell K, Ssebbowa P, Serwadda D, Quinn TC, Gray RH, et al. Hypertension, cardiovascular risk factors and antihypertensive medication utilisation among HIV-infected individuals in Rakai, Uganda. Trop Med Int Health. 2015;20(3):391–6.
Article
Google Scholar
Juma K, Reid M, Roy M, Vorkoper S, Temu TM, Levitt NS, et al. From HIV prevention to non-communicable disease health promotion efforts in sub-Saharan Africa: A Narrative Review. AIDS (London, England). 2018;32:S63–73.
Article
Google Scholar
Hyle EP, Naidoo K, Su AE, El-Sadr WM, Freedberg KA. HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care? J Acquir Immune Defic Syndr (1999). 2014;67 Suppl 1:S87–95.
Article
Google Scholar
Petersen M, Yiannoutsos CT, Justice A, Egger M. Observational research on NCDs in HIV-positive populations: conceptual and methodological considerations. J Acquir Immune Defic Syndr. 2014;67(Suppl. 1):S8–S16.
Article
Google Scholar
Patel P, Speight C, Maida A, Loustalot F, Giles D, Phiri S, et al. Integrating HIV and hypertension management in low-resource settings: lessons from Malawi. PLoS Med. 2018;15(3):e1002523.
Article
Google Scholar